Nephrogenic systemic fibrosis: review of 370 biopsy-confirmed cases

Zou, Z., Zhang, H. L., Roditi, G. H., Leiner, T., Kucharczyk, W. and Prince, M. R. (2011) Nephrogenic systemic fibrosis: review of 370 biopsy-confirmed cases. JACC: Cardiovascular Imaging, 4(11), pp. 1206-1216. (doi: 10.1016/j.jcmg.2011.08.013)

Full text not currently available from Enlighten.

Abstract

Discovery of an association between gadolinium-based contrast agents (GBCAs) and nephrogenic systemic fibrosis (NSF) has led to less use of GBCA-enhanced magnetic resonance imaging in dialysis patients and patients with severe renal failure at risk of NSF, and the virtual elimination of new cases of NSF. But shifting patients with renal failure to alternative imaging methods may subject patients to other risks (e.g., ionizing radiation or iodinated contrast). This review paper examines 370 NSF cases reported in 98 articles to analyze NSF risk factors. Eliminating multiple risk factors by limiting GBCA dose to a maximum of 0.1 mmol/kg, dialyzing patients undergoing dialysis quickly following GBCA administration, delaying GBCA in acute renal failure until after renal function returns or dialysis is initiated, and avoiding nonionic linear GBCA in patients with renal failure especially when there are proinflammatory conditions may substantially reduce the risk of NSF.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Roditi, Dr Giles
Authors: Zou, Z., Zhang, H. L., Roditi, G. H., Leiner, T., Kucharczyk, W., and Prince, M. R.
College/School:College of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing
Journal Name:JACC: Cardiovascular Imaging
Publisher:Elsevier Inc.
ISSN:1936-878X
ISSN (Online):1876-7591
Related URLs:

University Staff: Request a correction | Enlighten Editors: Update this record